HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nikoshkov, A. Articles by Luthman, H. Search for Related Content PubMed PubMed Citation Articles by Nikoshkov, A. Articles by Luthman, H.

A Conformation-Dependent Epitope in Addison’s Disease and Other Endocrinological Autoimmune Diseases Maps to a Carboxyl-Terminal Functional Domain of Human Steroid 21-Hydroxylase¹

Andrej Nikoshkov^2,*, Alberto Falorni, Svetlana Lajic^*,, Stefano Laureti, Anna Wedell^*, Åke Lernmark^§ and Holger Luthman^*

^* Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Internal Medicine and Endocrine and Metabolic Sciences, University of Perugia, Perugia, Italy; Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden; and ^§ Department of Medicine, University of Washington, Seattle, WA 98195-7790

Idiopathic Addison’s disease develops as a consequence of autoimmune destruction of steroid-producing cells in the adrenal gland. A major autoantigen is 21-hydroxylase (21OH; P450c21), which is involved in the biosynthesis of cortisol and aldosterone in the adrenal cortex. We selected a number of functionally important 21OH amino acid substitutions, found in patients with congenital adrenal hyperplasia, to study their effects on the binding of 21OH autoantibodies (21OHAb) to 21OH. The ability of 21OHAb to bind in vitro transcribed and translated wild-type 21OH and five different 21OH mutant proteins was quantified by liquid-phase assays. Sera from 21OHAb-positive patients with idiopathic Addison’s disease (n = 24), Graves’ disease (n = 3), and insulin-dependent diabetes mellitus (n = 1) were used. While the P105L, delE196, and G291S mutations had no effect on autoantibody binding, the P453S mutation had a considerable effect, and the R483P mutation almost completely abolished binding. Synthetic peptides corresponding to linear epitopes defined by amino acids 447–461 and 477–491 were unable to compete with wild-type 21OH for binding to autoantibodies. Direct 21OH DNA sequencing could not reveal any specific genetic variation in alleles found in 21OHAb-positive patients. We conclude that the region involving R483 plays a key role in the formation of a three-dimensional epitope in a functionally important C-terminal domain of the enzyme.

This article has been cited by other articles:

				M. Barbaro, S. Lajic, L. Baldazzi, A. Balsamo, P. Pirazzoli, A. Cicognani, A. Wedell, and E. Cacciari Functional Analysis of Two Recurrent Amino Acid Substitutions in the CYP21 Gene from Italian Patients with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2402 - 2407. [Abstract] [Full Text] [PDF]

				C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF]

				V. Kumar, M. Rajadhyaksha, and J. Wortsman Celiac Disease-Associated Autoimmune Endocrinopathies Clin. Vaccine Immunol., July 1, 2001; 8(4): 678 - 685. [Abstract] [Full Text] [PDF]